Oct 13, 2025 15:00
NAGE - Niagen Bioscience, Inc. Common Stock
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 6.68 0.2 (2.99%) | 0.0 (-0.07%) | -0.01 (-0.22%) | -0.04 (-0.51%) | 0.0 (0.0%) | 0.15 (2.23%) | --- | 0.0 (0.0%) |
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.
Category:
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Market Period:
Market
Earnings & Ratios
- Basic EPS:
- 0.05
- Diluted EPS:
- 0.04
- Basic P/E:
- 137.6
- Diluted P/E:
- 172.0
- RSI(14) 1m:
- 50.0
- VWAP:
- 6.88
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|